Arkema Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Arkema han disminuido a una tasa media anual de -39%, mientras que en la industria Chemicals los beneficios crecieron en un 7.4% anualmente. Los ingresos han ido disminuyendo a una tasa media de 0.8% al año. La rentabilidad financiera de Arkema es de 0.6%, y sus márgenes netos son de 0.2%.
Información clave
-39.02%
Tasa de crecimiento de los beneficios
-38.87%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 10.42% |
| Tasa de crecimiento de los ingresos | -0.81% |
| Rentabilidad financiera | 0.56% |
| Margen neto | 0.19% |
| Próxima actualización de resultados | 30 Jul 2026 |
Actualizaciones de resultados anteriores recientes
Artículo de análisis • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...Artículo de análisis • Nov 16
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...Recent updates
Artículo de análisis • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...
Actualización de narrativa • Apr 30
AKE: Battery Materials Expansion Will Support Future Rerating Potential
Arkema's analyst fair value estimate has moved slightly higher to about €81.56, reflecting analysts' updated assumptions on revenue growth, profit margins, and future P/E in light of recent upgrades, downgrades, and modest price target increases from several banks. Analyst Commentary Recent Street research on Arkema is mixed, but there is a clear cluster of more constructive calls that help frame how supportive analysts currently see the risk and reward around the stock.
Actualización de narrativa • Apr 15
AKE: Battery Expansion And Margin Execution Will Constrain Future Re Rating Potential
Arkema's fair value estimate has shifted from €44.00 to €50.00 as analysts factor in updated assumptions on revenue growth, profit margins and future P/E multiples, in line with a recent series of higher price targets and rating changes across major research firms. Analyst Commentary Recent Street research on Arkema presents a mixed picture, with several higher price targets sitting alongside at least one downgrade and more restrained views on upside.Actualización de narrativa • Apr 01
AKE: Battery Capacity Push Will Face Execution Risk And Uncertain Earnings Trajectory
Analysts have nudged Arkema's average price target higher to around €60 to €65, citing recent target increases from several banks and mixed rating changes that reflect a more balanced view on growth, margins, and a higher assumed future P/E multiple. Analyst Commentary Recent research has given Arkema a more mixed backdrop, with some banks lifting price targets while others turn more cautious on the shares, despite keeping targets within a relatively tight €60 to €65 range.
Actualización de narrativa • Mar 18
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Future Rerating
Arkema's analyst price target has edged up by €0.13 to €61.88, reflecting a blend of higher fair value P/E assumptions and mixed rating actions from analysts who have recently adjusted targets between €60 and €65. Analyst Commentary Bullish Takeaways Bullish analysts are comfortable assigning price targets in the €62 to €65 range, which supports the current blended target of €61.88 and signals confidence that Arkema can justify a slightly higher P/E than previously assumed.Actualización de narrativa • Mar 04
AKE: Battery Materials Expansion And Decarbonization Efforts Will Support Future Rerating
Our analyst price target for Arkema shifts from €65.06 to €61.88 as analysts factor in recent downgrades and lower external price targets, along with updated assumptions for revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on Arkema has been mixed, with both upgrades and downgrades sitting alongside reduced price targets.Actualización de narrativa • Feb 17
AKE: Battery Materials And Specialty Polymers Will Support Re Rating
Arkema's analyst price target has shifted from €85.00 to €80.00, as analysts factor in slightly softer assumptions on revenue growth, profit margins and future P/E, even as recent research updates include both an upgrade and a separate €5 adjustment to targets. Analyst Commentary Recent research on Arkema sends a mixed but broadly constructive signal, with the latest changes in price targets and ratings pointing to a more nuanced view of the company’s risk and reward profile.Artículo de análisis • Feb 13
After Leaping 26% Arkema S.A. (EPA:AKE) Shares Are Not Flying Under The Radar
The Arkema S.A. ( EPA:AKE ) share price has done very well over the last month, posting an excellent gain of 26%. Not...Actualización de narrativa • Feb 03
AKE: Battery Expansion Will Face Tougher Sector Backdrop And Execution Risk
Analysts have trimmed their price target on Arkema by €5, reflecting softer revenue growth assumptions, a slightly lower future P/E multiple, and sector headwinds highlighted in recent research, while keeping fair value broadly unchanged. Analyst Commentary Recent research points to a more cautious tone around Arkema, with pricing assumptions and sector views putting some pressure on sentiment.Actualización de narrativa • Jan 20
AKE: Battery Materials Expansion Will Face Tougher Sector Backdrop And Execution Risk
Narrative update Analysts have trimmed their price target on Arkema by €3 to €44, reflecting a lower fair value estimate along with updated views on revenue growth, margins and a reduced future P/E multiple, following recent cautious research on European chemicals and ingredients groups. Analyst Commentary Street research on Arkema has turned more cautious, with bearish analysts trimming price targets and flagging risks around growth visibility and valuation.Actualización de narrativa • Jan 06
AKE: Battery Materials Push Will Support Re Rating Despite Sector Downgrade
Analysts have trimmed their fair value estimate for Arkema to €85 from €95. This reflects lower assumed revenue growth, a slightly softer profit margin profile, a higher discount rate and more conservative future P/E expectations following recent cuts to Street price targets and a sector downgrade.Actualización de narrativa • Dec 21
AKE: Battery Materials Push Will Confront Tougher Sector Backdrop Ahead
The analyst fair value estimate for Arkema has been reduced from EUR 56 to EUR 47 as analysts factor in a higher discount rate, weaker revenue growth expectations, softer profit margins, and a sector wide shift toward more favored industrial gases and specialty distributors. Analyst Commentary Recent Street research reflects a more cautious stance on Arkema, with several bearish analysts trimming price targets and, in at least one case, reducing their rating.Actualización de narrativa • Dec 07
AKE: Sustainability And Decarbonization Investments Will Drive Future Rerating Despite Recent Downgrade
Arkema's analyst price target has been trimmed by about EUR 1 to EUR 65.06 as analysts factor in slightly softer long term growth and margin expectations, alongside a wave of recent price target cuts and a fresh Underweight rating from the Street. Analyst Commentary Recent Street research presents a mixed picture for Arkema, with several price target cuts but divergent views on the company’s medium term execution and earnings power.Actualización de narrativa • Nov 23
AKE: Recent Downgrade Will Be Offset By Sustainability Actions And Emissions Reductions
Analysts have lowered the fair value estimate for Arkema from €70.63 to €66.06, citing cautious sector sentiment and a series of reduced price targets across the chemical industry. Analyst Commentary Analysts continue to reassess Arkema's prospects in response to both company-specific and broader sector developments.Artículo de análisis • Nov 16
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...Artículo de análisis • Nov 12
Arkema S.A. (EPA:AKE) Just Reported, And Analysts Assigned A €66.94 Price Target
Investors in Arkema S.A. ( EPA:AKE ) had a good week, as its shares rose 6.6% to close at €52.60 following the release...Actualización de narrativa • Nov 06
AKE: Operational Improvements And Sustainability Efforts Will Drive Future Upside
The consensus analyst price target for Arkema has been reduced notably in recent updates, with targets now ranging from EUR 55 to EUR 80. Analysts cite cautious expectations for revenue growth and refining profit margin assumptions as reasons for the adjustment.Actualización de narrativa • Oct 23
Analysts Revise Arkema Price Target Lower Amid Cautious Optimism and Recent Sustainability Initiatives
Arkema's analyst price target has been revised downward from €72.75 to €70.63. This change reflects recent analyst adjustments driven by lower growth and profit expectations.Actualización de narrativa • Oct 09
New Capacity And R&D Focus Will Accelerate Renewable Transition
Arkema's analyst price target has been revised downward from €76.06 to €72.75. This change reflects analysts' expectations for slower revenue growth and a higher discount rate, even though profit margins have seen slight improvement.Actualización de narrativa • Sep 25
New Capacity And R&D Focus Will Accelerate Renewable Transition
Analysts have trimmed Arkema’s price target to €76.06, reflecting heightened caution around 2025 guidance cuts, persistent margin pressure, and weaker end-market demand, despite some confidence in the company’s long-term positioning. Analyst Commentary Bearish analysts cite increased risk of significant 2025 guidance cuts, particularly ahead of Q2 results.Artículo de análisis • Aug 27
Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
While Arkema S.A. ( EPA:AKE ) might not have the largest market cap around , it received a lot of attention from a...Artículo de análisis • Aug 06
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Arkema S.A. ( EPA:AKE ) shareholders are probably feeling a little disappointed, since its shares fell 6.5% to €58.65...Artículo de análisis • Jul 27
These 4 Measures Indicate That Arkema (EPA:AKE) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Jul 05
Potential Upside For Arkema S.A. (EPA:AKE) Not Without Risk
There wouldn't be many who think Arkema S.A.'s ( EPA:AKE ) price-to-earnings (or "P/E") ratio of 15.1x is worth a...Artículo de análisis • May 23
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.60
Arkema S.A. ( EPA:AKE ) will increase its dividend from last year's comparable payment on the 28th of May to €3.60...
Nueva narrativa • Dec 05
Specialty Materials And Renewable Energy Initiatives Ignite Earnings Growth And Margin Expansion
Strategic projects and acquisitions aim to enhance Arkema's earnings growth and stability, leveraging mega trends in energy and healthcare.Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Arkema. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 8,869 | 17 | 906 | 284 |
| 31 Dec 25 | 9,068 | 39 | 923 | 284 |
| 30 Sep 25 | 9,236 | 127 | 937 | 281 |
| 30 Jun 25 | 9,443 | 210 | 928 | 283 |
| 31 Mar 25 | 9,584 | 308 | 946 | 280 |
| 31 Dec 24 | 9,544 | 338 | 935 | 278 |
| 30 Sep 24 | 9,493 | 346 | 926 | 278 |
| 30 Jun 24 | 9,425 | 342 | 913 | 276 |
| 31 Mar 24 | 9,331 | 349 | 898 | 274 |
| 31 Dec 23 | 9,514 | 402 | 892 | 275 |
| 30 Sep 23 | 9,799 | 393 | 870 | 275 |
| 30 Jun 23 | 10,445 | 503 | 875 | 273 |
| 31 Mar 23 | 11,187 | 752 | 870 | 274 |
| 31 Dec 22 | 11,550 | 949 | 858 | 270 |
| 30 Sep 22 | 11,543 | 1,050 | 863 | 264 |
| 30 Jun 22 | 10,969 | 1,073 | 836 | 257 |
| 31 Mar 22 | 10,180 | 1,498 | 815 | 248 |
| 31 Dec 21 | 9,519 | 1,293 | 788 | 243 |
| 30 Sep 21 | 9,004 | 1,212 | 768 | 242 |
| 30 Jun 21 | 8,515 | 1,057 | 755 | 240 |
| 31 Mar 21 | 8,022 | 350 | 739 | 238 |
| 31 Dec 20 | 7,884 | 304 | 755 | 241 |
| 30 Sep 20 | 7,952 | 312 | 796 | 242 |
| 30 Jun 20 | 8,259 | 365 | 815 | 246 |
| 31 Mar 20 | 8,611 | 422 | 828 | 251 |
| 31 Dec 19 | 8,738 | 491 | 812 | 249 |
| 30 Sep 19 | 8,892 | 561 | 782 | 245 |
| 30 Jun 19 | 8,843 | 590 | 766 | 242 |
| 31 Mar 19 | 8,859 | 633 | 761 | 239 |
| 31 Dec 18 | 8,816 | 674 | 758 | 237 |
| 30 Sep 18 | 8,566 | 685 | 749 | 235 |
| 30 Jun 18 | 8,418 | 653 | 743 | 232 |
| 31 Mar 18 | 8,346 | 594 | 736 | 234 |
| 31 Dec 17 | 8,326 | 543 | 738 | 235 |
| 30 Sep 17 | 8,221 | 492 | 733 | 233 |
| 30 Jun 17 | 8,040 | 446 | 728 | 231 |
| 31 Mar 17 | 7,794 | 433 | 722 | 227 |
| 31 Dec 16 | 7,535 | 394 | 705 | 222 |
| 30 Sep 16 | 7,443 | 390 | 701 | 220 |
| 30 Jun 16 | 7,551 | 355 | 701 | 218 |
| 31 Mar 16 | 7,705 | 341 | 693 | 214 |
| 31 Dec 15 | 7,683 | 285 | 677 | 209 |
| 30 Sep 15 | 7,354 | 263 | 616 | 194 |
| 30 Jun 15 | 6,886 | 226 | 555 | 181 |
Ingresos de calidad: AKE tiene una única gran pérdida de €129.1M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: Los actuales márgenes de beneficio(0.2%) de AKE son inferiores a los del año pasado (3.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de AKE han disminuido en un 39% al año en los últimos 5 años.
Acelerando crecimiento: AKE ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: AKE tuvo un crecimiento negativo de los beneficios (-94.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (6.4%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AKE (0.6%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/20 01:14 |
| Precio de las acciones al final del día | 2026/05/20 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Arkema S.A. está cubierta por 33 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Gaurav Jain | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |